142 related articles for article (PubMed ID: 23995789)
21. Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1.
Morenos L; Chatterton Z; Ng JL; Halemba MS; Parkinson-Bates M; Mechinaud F; Elwood N; Saffery R; Wong NC
Mol Cancer; 2014 May; 13():123. PubMed ID: 24885794
[TBL] [Abstract][Full Text] [Related]
22. Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL).
Kasar S; Underbayev C; Hassan M; Ilev I; Degheidy H; Bauer S; Marti G; Lutz C; Raveche E; Batish M
PLoS One; 2016; 11(3):e0149331. PubMed ID: 26959643
[TBL] [Abstract][Full Text] [Related]
23. Immunomodulation and immune reconstitution in chronic lymphocytic leukemia.
Riches JC; Gribben JG
Semin Hematol; 2014 Jul; 51(3):228-34. PubMed ID: 25048786
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.
Cui B; Chen L; Zhang S; Mraz M; Fecteau JF; Yu J; Ghia EM; Zhang L; Bao L; Rassenti LZ; Messer K; Calin GA; Croce CM; Kipps TJ
Blood; 2014 Jul; 124(4):546-54. PubMed ID: 24914134
[TBL] [Abstract][Full Text] [Related]
25. Role of microRNAs in Chronic Lymphocytic Leukemia.
Autore F; Ramassone A; Stirparo L; Pagotto S; Fresa A; Innocenti I; Visone R; Laurenti L
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569845
[TBL] [Abstract][Full Text] [Related]
26. Research progress in effects of microRNA
Wen D; Wang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):743-749. PubMed ID: 37539577
[TBL] [Abstract][Full Text] [Related]
27. Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation.
Sevcikova A; Fridrichova I; Nikolaieva N; Kalinkova L; Omelka R; Martiniakova M; Ciernikova S
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174123
[TBL] [Abstract][Full Text] [Related]
28. Circular RNAs: pivotal role in the leukemogenesis and novel indicators for the diagnosis and prognosis of acute myeloid leukemia.
Rahmati A; Mafi A; Soleymani F; Babaei Aghdam Z; Masihipour N; Ghezelbash B; Asemi R; Aschner M; Vakili O; Homayoonfal M; Asemi Z; Sharifi M; Azadi A; Mirzaei H; Aghadavod E
Front Oncol; 2023; 13():1149187. PubMed ID: 37124518
[TBL] [Abstract][Full Text] [Related]
29. The Molecular Mechanisms and Function of miR-15a/16 Dysregulation in Fibrotic Diseases.
Wen D; Zhang H; Zhou Y; Wang J
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555676
[TBL] [Abstract][Full Text] [Related]
30. Circular RNAs in acute myeloid leukemia.
Singh V; Uddin MH; Zonder JA; Azmi AS; Balasubramanian SK
Mol Cancer; 2021 Nov; 20(1):149. PubMed ID: 34794438
[TBL] [Abstract][Full Text] [Related]
31. miR-151a-3p-rich small extracellular vesicles derived from gastric cancer accelerate liver metastasis via initiating a hepatic stemness-enhancing niche.
Li B; Xia Y; Lv J; Wang W; Xuan Z; Chen C; Jiang T; Fang L; Wang L; Li Z; He Z; Li Q; Xie L; Qiu S; Zhang L; Zhang D; Xu H; Xu Z
Oncogene; 2021 Oct; 40(43):6180-6194. PubMed ID: 34535770
[TBL] [Abstract][Full Text] [Related]
32. An immunotherapeutic approach to decipher the role of long non-coding RNAs in cancer progression, resistance and epigenetic regulation of immune cells.
Varier KM; Dhandapani H; Liu W; Song J; Wang C; Hu A; Ben-David Y; Shen X; Li Y; Gajendran B
J Exp Clin Cancer Res; 2021 Jul; 40(1):242. PubMed ID: 34303380
[TBL] [Abstract][Full Text] [Related]
33. Low miR-16 expression induces regulatory CD4
Zhu T; Lin Z; Han S; Wei Y; Lu G; Zhang Y; Xiao W; Wang Z; Jia X; Gong W
Am J Cancer Res; 2021; 11(4):1540-1556. PubMed ID: 33948372
[TBL] [Abstract][Full Text] [Related]
34. DLEU2 participates in lymphovascular invasion and inhibits cervical cancer cell proliferation, migration, and invasion.
Zhang H; Wang X; Zhang Q; Ma Y; Wang Z
Int J Clin Exp Pathol; 2020; 13(8):2018-2026. PubMed ID: 32922596
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA DLEU2 predicts a poor prognosis and enhances malignant properties in laryngeal squamous cell carcinoma through the miR-30c-5p/PIK3CD/Akt axis.
Li X; Xu F; Meng Q; Gong N; Teng Z; Xu R; Zhao M; Xia M
Cell Death Dis; 2020 Jun; 11(6):472. PubMed ID: 32555190
[TBL] [Abstract][Full Text] [Related]
36. System level characterization of small molecule drugs and their affected long noncoding RNAs.
Yang H; Jiang Y; Zhang Y; Xu Y; Zhang C; Han J; Su F; Liu X; Mi K; Liu B; Shang D
Aging (Albany NY); 2019 Dec; 11(24):12428-12451. PubMed ID: 31852840
[TBL] [Abstract][Full Text] [Related]
37. Recent Progress on Circular RNA Research in Acute Myeloid Leukemia.
Jamal M; Song T; Chen B; Faisal M; Hong Z; Xie T; Wu Y; Pan S; Yin Q; Shao L; Zhang Q
Front Oncol; 2019; 9():1108. PubMed ID: 31781482
[TBL] [Abstract][Full Text] [Related]
38. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
Chava S; Reynolds CP; Pathania AS; Gorantla S; Poluektova LY; Coulter DW; Gupta SC; Pandey MK; Challagundla KB
Mol Oncol; 2020 Jan; 14(1):180-196. PubMed ID: 31637848
[TBL] [Abstract][Full Text] [Related]
39. Interplay between miRNAs and host genes and their role in cancer.
Liu B; Shyr Y; Cai J; Liu Q
Brief Funct Genomics; 2018 Jul; 18(4):255-266. PubMed ID: 30785618
[TBL] [Abstract][Full Text] [Related]
40. Role of Circular RNA DLEU2 in Human Acute Myeloid Leukemia.
Wu DM; Wen X; Han XR; Wang S; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Chen GQ; Lu J; Zheng YL
Mol Cell Biol; 2018 Oct; 38(20):. PubMed ID: 30037980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]